Insiders Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Real-time Estimate Cboe BZX Other stock markets 02:04:55 2024-04-29 pm EDT			5-day change	1st Jan Change
34.58 ^USD	+3.04%		+4.55%	+61.76%

Apr. 19	Sector Update: Health Care Stocks Steady Pre-Bell Friday	MT
Apr. 19	Spyre Therapeutics Files Mixed-Securities Shelf Registration for About 33.4 Million Shares	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Spyre Therapeutics, Inc. Announces Board Changes	Feb. 05	CI
Aeglea BioTherapeutics, Inc. will Change its Name to Spyre Therapeutics, Inc	Nov. 28	CI
Aeglea BioTherapeutics Changes Name to Spyre Therapeutics; CEO Appointed	Nov. 27	MT
Aeglea BioTherapeutics, Inc. Appoints Cameron Turtle as Chief Executive Officer	Nov. 27	CI
Aeglea BioTherapeutics, Inc. Announces Executive Changes	Nov. 27	CI
Aeglea BioTherapeutics, Inc. Announces Appointment of Cameron Turtle as Principal Executive Officer	23-10-10	CI
Aeglea BioTherapeutics Appoints Scott Burrows as CFO	23-09-05	MT
Aeglea Biotherapeutics Expands Executive Leadership Team with Appointment of Industry Veterans Scott Burrows and Heidy Abreu King-Jones	23-09-05	CI
Aeglea BioTherapeutics, Inc. Announces Executive Changes	23-09-05	CI
Aeglea Biotherapeutics, Inc. Announces the Termination of Jeffrey Goldberg as Chief Executive Officer	23-05-19	CI
Aeglea BioTherapeutics, Inc. Announces Executive Changes	23-05-19	CI
Aeglea BioTherapeutics Cuts 15% of Workforce, Halts Development Programs; COO to Leave; Shares Fall	23-01-06	MT
Aeglea Biotherapeutics, Inc. Announces Resignation of Leslie Sloan as Chief Operating Officer	23-01-06	CI
Anticipation Ahead of Powell's Speech Supports Modest Rise in Exchange Traded Funds Premarket Wednesday	22-11-30	MT
Aeglea BioTherapeutics Names Jeffrey Goldberg Chief Executive Officer	22-11-30	MT
Aeglea BioTherapeutics, Inc. Appoints Jeffrey M. Goldberg as President, and Member of the Board of Directors	22-11-30	CI
Aeglea Biotherapeutics, Inc. Announces Chief Executive Officer Changes	22-11-30	CI
Aeglea BioTherapeutics Promotes Linda Neuman to Chief Medical Officer	22-11-16	MT
Aeglea BioTherapeutics, Inc. Appoints Linda Neuman as Chief Medical Officer	22-11-15	CI
Aeglea BioTherapeutics to Restructure; Cuts 25% of Headcount, Appoints Jim Kastenmayer as Interim CEO	22-08-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Insiders

Filters